Results for "The Role of Distributors in the U.S. Specialty Pharmaceuticals Value Chain"
Reimagining the Pharmaceutical Supply Chain
HDA's President and CEO Chip Davis participated in a panel discussion at The Milken Institute’s 2022 Future of Health Summit entitled, “Reimagining the Pharmaceutical Supply Chain in the United States,” discussing the fundamental resilience of the pharmaceutical supply chain, while exploring the gaps and deepened growing health inequities unearthed by recent public health events.
2022 Serialization Readiness Survey
The seventh edition of the HDA Research Foundation's survey shares the current readiness of manufacturers and distributors to meet Drug Supply Chain Security Act (DSCSA) requirements.